0001209191-18-004680.txt : 20180122 0001209191-18-004680.hdr.sgml : 20180122 20180122084104 ACCESSION NUMBER: 0001209191-18-004680 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180118 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAWRENCE DAVID CENTRAL INDEX KEY: 0001272353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31938 FILM NUMBER: 18538861 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACORDA THERAPEUTICS INC CENTRAL INDEX KEY: 0001008848 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 BUSINESS PHONE: 914-347-4300 MAIL ADDRESS: STREET 1: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-18 0 0001008848 ACORDA THERAPEUTICS INC ACOR 0001272353 LAWRENCE DAVID 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 0 1 0 0 Chief, Bus. Ops & PAO Common Stock 2018-01-18 4 M 0 582 19.81 A 5275 D Common Stock 2018-01-18 4 S 0 582 27.00 D 4693 D Common Stock 2018-01-19 4 M 0 30418 19.81 A 35111 D Common Stock 2018-01-19 4 S 0 29918 27.5756 D 5193 D Common Stock 2018-01-19 4 S 0 500 28.38 D 4693 D Employee Stock Option (right to buy) 19.81 2018-01-18 4 M 0 582 0.00 D 2018-03-05 Common Stock 582 30418 D Employee Stock Option (right to buy) 19.81 2018-01-19 4 M 0 30418 0.00 D 2018-03-05 Common Stock 30418 0 D Exercise and sales pursuant to a 10b5-1 plan. The exercised options were scheduled to expire in 2018 on the expiration date reported within Table II unless exercised. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $27.05 to $27.80 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $28.05 to $28.60 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The shares subject to these options vested in installments and were fully vested on 1/01/2012. /s/ David Lawrence 2018-01-22